Summary

Executive Summary



Azoth Analytics has released a research report titled “Global Biosimulation Market (2024 Edition)” which provides an analysis of the Global Biosimulation industry in terms of market segmentation By Type (Services, Software), By Application (Drug Development, Drug Discovery, Other Applications), By Deployment Model Outlook (Cloud-based, On-premise, Hybrid Model) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Biosimulation Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Biosimulation market showcased growth at a CAGR of 16.05% during 2020-2023. The market was valued at USD 6095.20 Million in 2023 which is expected to reach USD 14571.87 Million in 2030.

Biosimulation involves the use of computer-aided modeling and simulation techniques to predict the behaviour and outcomes of biological processes, drug interactions, and disease progression. It plays a critical role in drug discovery, development, and precision medicine by minimizing costs and reducing time-to-market for new therapies.

The growth of this Market is expected to be fuelled by ongoing technological advancements, increasing adoption across various sectors, and the expanding applications of Biosimulation in defence, industrial bioprocessing, nutraceuticals, and agri-food production.

Americas holds the largest market share driven by advanced R&D infrastructure, strong pharmaceutical and biotechnology industries, and favourable regulatory support from agencies like the FDA. The United States dominates this region due to extensive investments in drug discovery and precision medicine.



Scope of the Report:



• The report analyses the Biosimulation Market by Value (USD Million).

• The report analyses the Biosimulation Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).

• The report presents the analysis of Biosimulation Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.

• The report analyses the Biosimulation Market By Type (Services, Software)

• The report analyses the Biosimulation Market By Application (Drug Development, Drug Discovery, Other Applications).

• The report analyses the Biosimulation Market By Deployment Model Outlook (Cloud-based, On-premise, Hybrid Model).

• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Type, By Application and By Deployment Model Outlook.

• Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analyzed in the report include Certara, Inc, Advanced Chemistry Development, Inc., Simulations Plus, Inc, Chemical Computing Group, Dassault Systèmes Scientific, Schrodinger, Inc., Genedata, MathWorks, Netabolics, Cellworks.

ページTOPに戻る

Table of Contents

Table of Content



1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology



2. Analyst Recommendations

2.1 Advancements in Precision Oncology

2.2 Integration with Digital Twins



3. Global Biosimulation Market: Historic and Forecast

3.1 Impact Analysis of Macro Economic Factors on Biosimulation Market

3.2 Incorporation of Biosimulation in FDA guidance

3.3 List of systems biology modeling software

3.4 Global Biosimulation Market: Dashboard

3.5 Global Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

3.6 Global Biosimulation Market: Market Value Assessment

3.7 Global Biosimulation Market Segmentation: By Type

3.7.1 Global Biosimulation Market, By Type Overview

3.7.2 Global Biosimulation Market Attractiveness Index, By Type

3.7.3 Global Biosimulation Market Size, By Services, By Value, 2020H-2030F (USD Million & CAGR)

3.7.4 Global Biosimulation Market Size, By Software, By Value, 2020H-2030F (USD Million & CAGR)

3.8 Global Biosimulation Market Segmentation: By Application

3.8.1 Global Biosimulation Market, By Application Overview

3.8.2 Global Biosimulation Market Attractiveness Index, By Application

3.8.3 Global Biosimulation Market Size, By Drug Development, By Value, 2020H-2030F (USD Million & CAGR)

3.8.4 Global Biosimulation Market Size, By Drug Discovery, By Value, 2020H-2030F (USD Million & CAGR)

3.8.5 Global Biosimulation Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)

3.9 Global Biosimulation Market Segmentation: By Deployment Model Outlook

3.9.1 Global Biosimulation Market, By Deployment Model Outlook Overview

3.9.2 Global Biosimulation Market Attractiveness Index, By Deployment Model Outlook

3.9.3 Global Biosimulation Market Size, By Cloud-based, By Value, 2020H-2030F (USD Million & CAGR)

3.9.4 Global Biosimulation Market Size, By On-premise, By Value, 2020H-2030F (USD Million & CAGR)

3.9.5 Global Biosimulation Market Size, By Hybrid Model, By Value, 2020H-2030F (USD Million & CAGR)



4. Biosimulation Market, Region Analysis

4.1 Regional Coverage of the Study

4.2 Regional Snapshot



5. Americas Biosimulation Market: Historic and Forecast

5.1 Americas Biosimulation Market: Snapshot

5.2 Americas Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

5.3 Americas Biosimulation Market: Key Factors

5.4 Americas Biosimulation Market: Segment Analysis

5.5 Americas Biosimulation Market Segmentation: By Type

5.5.1 Americas Biosimulation Market, By Type Overview

5.5.2 Americas Biosimulation Market Size, By Services, By Value, 2020H-2030F (USD Million & CAGR)

5.5.3 Americas Biosimulation Market Size, By Software, By Value, 2020H-2030F (USD Million & CAGR)

5.6 Americas Biosimulation Market Segmentation: By Application

5.6.1 Americas Biosimulation Market, By Application Overview

5.6.2 Americas Biosimulation Market Size, By Drug Development, By Value, 2020H-2030F (USD Million & CAGR)

5.6.3 Americas Biosimulation Market Size, By Drug Discovery, By Value, 2020H-2030F (USD Million & CAGR)

5.6.4 Americas Biosimulation Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)

5.7 Americas Biosimulation Market Segmentation: By Deployment Model Outlook

5.7.1 Americas Biosimulation Market, By Deployment Model Outlook Overview

5.7.2 Americas Biosimulation Market Size, By Cloud-based, By Value, 2020H-2030F (USD Million & CAGR)

5.7.3 Americas Biosimulation Market Size, By On-premise, By Value, 2020H-2030F (USD Million & CAGR)

5.7.4 Americas Biosimulation Market Size, By Hybrid, By Value, 2020H-2030F (USD Million & CAGR)

5.8 Americas Biosimulation Market Segmentation: By Country

5.8.1 Americas Biosimulation Market, by Country Overview

5.8.2 United States Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

5.8.2.1 United States Biosimulation Market, By Type

5.8.2.2 United States Biosimulation Market, By Application

5.8.2.3 United States Biosimulation Market, By Deployment Model Outlook

5.8.3 Canada Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

5.8.3.1 Canada Biosimulation Market, By Type

5.8.3.2 Canada Biosimulation Market, By Application

5.8.3.3 Canada Biosimulation Market, By Deployment Model Outlook

5.8.4 Rest of Americas Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

5.8.4.1 Rest of Americas Biosimulation Market, By Type

5.8.4.2 Rest of Americas Biosimulation Market, By Application

5.8.4.3 Rest of Americas Biosimulation Market, By Deployment Model Outlook



6. Europe Biosimulation Market: Historic and Forecast

6.1 Europe Biosimulation Market: Snapshot

6.2 Europe Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.3 Europe Biosimulation Market: Key Factors

6.4 Europe Biosimulation Market: Segment Analysis

6.5 Europe Biosimulation Market Segmentation: By Type

6.5.1 Europe Biosimulation Market, By Type Overview

6.5.2 Europe Biosimulation Market Size, By Services, By Value, 2020H-2030F (USD Million & CAGR)

6.5.3 Europe Biosimulation Market Size, By Software, By Value, 2020H-2030F (USD Million & CAGR)

6.6 Europe Biosimulation Market Segmentation: By Application

6.6.1 Europe Biosimulation Market, By Application Overview

6.6.2 Europe Biosimulation Market Size, By Drug Development, By Value, 2020H-2030F (USD Million & CAGR)

6.6.3 Europe Biosimulation Market Size, By Drug Discovery, By Value, 2020H-2030F (USD Million & CAGR)

6.6.4 Europe Biosimulation Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)

6.7 Europe Biosimulation Market Segmentation: By Deployment Model Outlook

6.7.1 Europe Biosimulation Market, By Deployment Model Outlook Overview

6.7.2 Europe Biosimulation Market Size, By Cloud-based, By Value, 2020H-2030F (USD Million & CAGR)

6.7.3 Europe Biosimulation Market Size, By On-premise, By Value, 2020H-2030F (USD Million & CAGR)

6.7.4 Europe Biosimulation Market Size, By Hybrid, By Value, 2020H-2030F (USD Million & CAGR)

6.8 Europe Biosimulation Market Segmentation: By Country

6.8.1 Europe Biosimulation Market, by Country Overview

6.8.2 Germany Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.2.1 Germany Biosimulation Market, By Type

6.8.2.2 Germany Biosimulation Market, By Application

6.8.2.3 Germany Biosimulation Market, By Deployment Model Outlook

6.8.3 United Kingdom Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.3.1 United Kingdom Biosimulation Market, By Type

6.8.3.2 United Kingdom Biosimulation Market, By Application

6.8.3.3 United Kingdom Biosimulation Market, By Deployment Model Outlook

6.8.4 France Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.4.1 France Biosimulation Market, By Type

6.8.4.2 France Biosimulation Market, By Application

6.8.4.3 France Biosimulation Market, By Deployment Model Outlook

6.8.5 Italy Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.5.1 Italy Biosimulation Market, By Type

6.8.5.2 Italy Biosimulation Market, By Application

6.8.5.3 Italy Biosimulation Market, By Deployment Model Outlook

6.8.6 Spain Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.6.1 Spain Biosimulation Market, By Type

6.8.6.2 Spain Biosimulation Market, By Application

6.8.6.3 Spain Biosimulation Market, By Deployment Model Outlook

6.8.7 Rest of Europe Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

6.8.7.1 Rest of Europe Biosimulation Market, By Type

6.8.7.2 Rest of Europe Biosimulation Market, By Application

6.8.7.3 Rest of Europe Biosimulation Market, By Deployment Model Outlook



7. Asia Pacific Biosimulation Market: Historic and Forecast

7.1 Asia Pacific Biosimulation Market: Snapshot

7.2 Asia Pacific Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

7.3 Asia Pacific Biosimulation Market: Key Factors

7.4 Asia Pacific Biosimulation Market: Segment Analysis

7.5 Asia Pacific Biosimulation Market Segmentation: By Type

7.5.1 Asia Pacific Biosimulation Market, By Type Overview

7.5.2 Asia Pacific Biosimulation Market Size, By Services, By Value, 2020H-2030F (USD Million & CAGR)

7.5.3 Asia Pacific Biosimulation Market Size, By Software, By Value, 2020H-2030F (USD Million & CAGR)

7.6 Asia Pacific Biosimulation Market Segmentation: By Application

7.6.1 Asia Pacific Biosimulation Market, By Application Overview

7.6.2 Asia Pacific Biosimulation Market Size, By Drug Development, By Value, 2020H-2030F (USD Million & CAGR)

7.6.3 Asia Pacific Biosimulation Market Size, By Drug Discovery, By Value, 2020H-2030F (USD Million & CAGR)

7.6.4 Asia Pacific Biosimulation Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)

7.7 Asia Pacific Biosimulation Market Segmentation: By Deployment Model Outlook

7.7.1 Asia Pacific Biosimulation Market, By Deployment Model Outlook Overview

7.7.2 Asia Pacific Biosimulation Market Size, By Cloud-based, By Value, 2020H-2030F (USD Million & CAGR)

7.7.3 Asia Pacific Biosimulation Market Size, By On-premise, By Value, 2020H-2030F (USD Million & CAGR)

7.7.4 Asia Pacific Biosimulation Market Size, By Hybrid, By Value, 2020H-2030F (USD Million & CAGR)

7.8 Asia Pacific Biosimulation Market Segmentation: By Country

7.8.1 Asia Pacific Biosimulation Market, by Country Overview

7.8.2 China Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

7.8.2.1 China Biosimulation Market, By Type

7.8.2.2 China Biosimulation Market, By Application

7.8.2.3 China Biosimulation Market, By Deployment Model Outlook

7.8.3 Japan Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

7.8.3.1 Japan Biosimulation Market, By Type

7.8.3.2 Japan Biosimulation Market, By Application

7.8.3.3 Japan Biosimulation Market, By Deployment Model Outlook

7.8.4 India Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

7.8.4.1 India Biosimulation Market, By Type

7.8.4.2 India Biosimulation Market, By Application

7.8.4.3 India Biosimulation Market, By Deployment Model Outlook

7.8.5 Rest of Asia Pacific Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

7.8.5.1 Rest of Asia Pacific Biosimulation Market, By Type

7.8.5.2 Rest of Asia Pacific Biosimulation Market, By Application

7.8.5.3 Rest of Asia Pacific Biosimulation Market, By Deployment Model Outlook



8. Middle East and Africa Biosimulation Market: Historic and Forecast

8.1 Middle East and Africa Biosimulation Market: Snapshot

8.2 Middle East and Africa Biosimulation Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)

8.3 Middle East and Africa Biosimulation Market: Key Factors

8.4 Middle East and Africa Biosimulation Market: Segment Analysis

8.5 Middle East and Africa Biosimulation Market Segmentation: By Type

8.5.1 Middle East and Africa Biosimulation Market, By Type Overview

8.5.2 Middle East and Africa Biosimulation Market Size, By Services, By Value, 2020H-2030F (USD Million & CAGR)

8.5.3 Middle East and Africa Biosimulation Market Size, By Software, By Value, 2020H-2030F (USD Million & CAGR)

8.6 Middle East and Africa Biosimulation Market Segmentation: By Application

8.6.1 Middle East and Africa Biosimulation Market, By Application Overview

8.6.2 Middle East and Africa Biosimulation Market Size, By Drug Development, By Value, 2020H-2030F (USD Million & CAGR)

8.6.3 Middle East and Africa Biosimulation Market Size, By Drug Discovery, By Value, 2020H-2030F (USD Million & CAGR)

8.6.4 Middle East and Africa Biosimulation Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)

8.7 Middle East and Africa Biosimulation Market Segmentation: By Deployment Model Outlook

8.7.1 Middle East and Africa Biosimulation Market, By Deployment Model Outlook Overview

8.7.2 Middle East and Africa Biosimulation Market Size, By Cloud-based, By Value, 2020H-2030F (USD Million & CAGR)

8.7.3 Middle East and Africa Biosimulation Market Size, By On-premise, By Value, 2020H-2030F (USD Million & CAGR)

8.7.4 Middle East and Africa Biosimulation Market Size, By Hybrid, By Value, 2020H-2030F (USD Million & CAGR)



9. Market Dynamics

9.1 Impact assessment of Market Dynamics on Biosimulation Market

9.2 Drivers

9.3 Restraints

9.4 Trends



10. Industry Ecosystem Analysis

10.1 Porter Analysis



11. Competitive Positioning

11.1 Companies’ Product Positioning

11.2 Market Position Matrix

11.3 Market Share Analysis of Biosimulation Market

11.4 Company Profiles

11.4.1 Certara, Inc.

11.4.2 Advanced Chemistry Development, Inc.

11.4.3 Simulations Plus, Inc.

11.4.4 Chemical Computing Group

11.4.5 Dassault Systèmes Scientific

11.4.6 Schrodinger, Inc.

11.4.7 Genedata

11.4.8 MathWorks

11.4.9 Netabolics

11.4.10 Cellworks



12. About Us & Disclaimer